대한물리의학회지 (Journal of the Korean Society of Physical Medicine)

  • 제19권3호
  • /
  • Pages.37-46
  • /
  • 2024
  • /
  • 1975-311X(pISSN)
  • /
  • 2287-7215(eISSN)
대한물리의학회 (The Korean Society of Physical Medicine)
권호 표지
DOI QR코드

DOI QR Code

Nationwide Cross-sectional Analysis of Determinant Agents for Sarcopenia in Men in Their Forties: Based on the E WGSOP Criteria

  • Jongseok Hwang (Sarcopenia Research Center, Institute of Human Ecology & Kinesiology, Yeungnam University)
  • 투고 : 2024.07.31
  • 심사 : 2024.08.07
  • 발행 : 2024.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

PURPOSE: This study examined sarcopenia in middle-aged men aged 40 to 49 years. METHODS: The study design was a nationwide cross-sectional study involving 1,564 participants. The participants were divided into two groups based on their skeletal muscle mass index scores, with 36 and 1,528 individuals classified into the sarcopenia and normal groups, respectively. The variables examined included age, height, weight, body mass index (BMI), waist circumference, skeletal muscle mass index, and systolic and diastolic blood pressure. The results from blood tests included fasting glucose, triglycerides, and total cholesterol levels. The smoking and drinking status were also recorded. RESULTS: The anthropometric variables, such as weight, BMI, and waist circumference, revealed significant differences between the two groups (p < .05), except for height (p > .05). In addition, total cholesterol in the laboratory test and drink status were significant between the two groups (p < .05). CONCLUSION: This study identified significant determinants for sarcopenia among community-dwelling middle-aged men.

키워드

참고문헌

  1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-1S. 
  2. Critchley MJTL. The neurology of old age. 1931;217(5621):1119-27. 
  3. Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int. 2012;12(3):388-96. 
  4. Kulik CT, Ryan S, Harper S, et al. Aging populations and management. Academy of Management Briarcliff Manor, NY. 2014. pp.929-35. 
  5. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-8.
  6. Liu X, Hao Q, Yue J, et al. Sarcopenia, Obesity and Sarcopenia Obesity in Comparison: Prevalence, Metabolic Profile, and Key Differences: Results from WCHAT Study. J Nutr Health Aging. 2020;24(4):429-37. 
  7. Hai S, Wang H, Cao L, et al. Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older. BMC Geriatr. 2017;17(1):187. 
  8. Chan R, Leung J, Woo J. A Prospective Cohort Study to Examine the Association Between Dietary Patterns and Sarcopenia in Chinese Community-Dwelling Older People in Hong Kong. J Am Med Dir Assoc. 2016 ;17(4):336-42. 
  9. Nishiguchi S, Yamada M, Fukutani N, et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2015;16(2):120-4. 
  10. Kang SY, Lim GE, Kim YK, et al. Association between Sarcopenic Obesity and Metabolic Syndrome in Postmenopausal Women: A Cross-sectional Study Based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011. J Bone Metab. 2017;24(1):9-14. 
  11. Velazquez-Alva MC, Irigoyen Camacho ME, Lazarevich I, et al. Comparison of the prevalence of sarcopenia using skeletal muscle mass index and calf circumference applying the European consensus definition in elderly Mexican women. Geriatr Gerontol Int. 2017;17(1):161-70. 
  12. Lee HN KB. Convergence Factors Affecting Sarcopenia in Middle-Aged and Older Women in Korea: A Cross Sectional Study by Using 5th KNHANES. Journ Kor Converg Soc. 2020;11(11):405-16. 
  13. Silva TLD, Mulder AP. Sarcopenia and poor muscle quality associated with severe obesity in young adults and middle-aged adults. Clin Nutr ESPEN. 2021;45:299-305. 
  14. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693. 
  15. Hashemi R, Shafiee G, Motlagh AD, et al. Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study. Arch Gerontol Geriatr. 2016;66:18-22. 
  16. Santos VRd, Araujo MYC, Cardoso MR, et al. Association of insufficient physical activity with sarcopenia and sarcopenic obesity in individuals aged 50 years or more. Revista de Nutricao. 2017;30:175-84. 
  17. Huschtscha Z, Parr A, Porter J, et al. Sarcopenic Characteristics of Active Older Adults: a Cross-Sectional Exploration. Sports Med Open. 2021;7(1):32. 
  18. Hwang J, Park S. Gender-Specific Risk Factors and Prevalence for Sarcopenia among Community-Dwelling Young-Old Adults. Int J Environ Res Public Health. 2022;19(12):7232. 
  19. Hwang J, Park S. Sex Differences of Sarcopenia in an Elderly Asian Population: The Prevalence and Risk Factors. Int J Environ Res Public Health. 2022;19(19):11980. 
  20. Hwang J, Park S. Gender-Specific Prevalence and Risk Factors of Sarcopenic Obesity in the Korean Elderly Population: A Nationwide Cross-Sectional Study. Int J Environ Res Public Health. 2023;20(2):1140. 
  21. Lexell J, Downham D, Sjostrom M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of healthy men between 15 and 83 years. J Neurol Sci. 1986;72(2-3):211-22. 
  22. Kehayias JJ, Fiatarone MA, Zhuang H, et al. Total body potassium and body fat: relevance to aging. Am J Clin Nutr. 1997;66(4):904-10. 
  23. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8. 
  24. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96. 
  25. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. 
  26. Belarmino G, Gonzalez MC, Sala P, et al. Diagnosing Sarcopenia in Male Patients With Cirrhosis by Dual-Energy X-Ray Absorptiometry Estimates of Appendicular Skeletal Muscle Mass. JPEN J Parenter Enteral Nutr. 2018;42(1):24-36. 
  27. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755-63. 
  28. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosisReport of the European Working Group on Sarcopenia in Older PeopleA. J. Cruz-Gentoft et al. 2010;39(4):412-23. 
  29. Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obesity Facts. 2022;15(3):321-35. 
  30. Hwang J. Age-Related Loss of Skeletal Muscle and Associated Risk Factors in Middle-Aged Men: A Comprehensive Study. J Korean Soc Phys Med. 2023;18(2):13-21. 
  31. Hwang J. Coexistence of Age-related Loss of Skeletal Muscle Mass and Obesity in Korean Men in Their Thirties: Understanding Incidence Rate and Key Influencing Elements. J Korean Soc Phys Med. 2023;18(4):37-45. 
  32. Hwang J. Analyzing Proportion and Susceptibility Markers of Sarcopenia In Korean Younger Female. J Korean Soc Phys Med. 2023;18(4):19-27. 
  33. Hwang J. Comprehensive Investigation on the Prevalence and Risk Factors of Coexistence of Age-related Loss of Skeletal Muscle Mass and Obesity among Males in Their 40s. J Korean Soc Phys Med. 2023;18(3):1-9. 
  34. Hwang J. Prevalence, Anthropometric Risk Factors, and Clinical Risk Factors in Sarcopenic Women in Their 40s. J Korean Soc Phys Med. 2023;18(2):23-31. 
  35. Hwang J. Unraveling the Contributing Factors of Sarcopenia in Young Korean Male Adults: A Study of Occurrence, Somatometric, Biochemical, and Behavioral Characteristics. J Korean Soc Phys Med. 2023;18(3):21-30. 
  36. Hwang J, Kim N-h. Comprehensive Cross-sectional Study of Sarcopenia in Young Korean Women: Assessing Body Dimensions, Clinical Indicators, and Behavioral Traits for Hazardous Components and Proportional Analysis. J Korean Soc Phys Med. 2023. 
  37. Hwang J, Lee J. Factors Influencing Age-Related Loss of Skeletal Muscle Mass in Young Korean Men. J Korean Soc Phys Med. 2023;18(4):67-75. 
  38. Hwang J, Moon IY. Exploring incidence and potential risk factors of sarcopenic obesity among middle-aged women residing in a community. J Korean Soc Phys Med. 2023;18(3):11-9. 
  39. Hwang J, Park S. A Korean Nationwide Cross-Sectional Study Investigating Risk Factors, Prevalence, and Characteristics of Sarcopenia in Men in Early Old Age. Healthcare. MDPI. 2023. pp.2860. 
  40. Hwang J. Distribution Dynamics and Proposed Determinants: Exploring Morphological, Clinical Laboratory, and Lifestyle Factors in the Coexistence of Age-Related Skeletal Muscle Mass L oss and Obesity among Y oung Men: A Nationwide Cross-Sectional Study. J Korean Soc Phys Med. 2024;19(1):31-41. 
  41. Hwang J. Sarcopenic Obesity Frequency and Associated Risk Factors in Young Korean Women: A Comprehensive Cross-Sectional Analysis. J Korean Soc Phys Med. 2024;19(1):43-51. 
  42. Hwang J, Lee C-R. The Hazardous Components and Prevailing Rate of Sarcopenic Obesity in Younger Women: Based on 2008-2011 Korean National Health and Nutrition Examination Surveys. Journal of The Korean Society of Integrative Medicine. 2024;12(2):1-10. 
  43. Hwang J, Park S. A Comprehensive Risk Factor Exploration: Korean Nationwide Cross-Sectional Study of Sarcopenia Obesity in Young-Old Males-Investigating the Prevalence, Somatometric, Biochemical, and Behavioral Traits. Healthcare. 2024;12(6):700. 
  44. Hwang J, Park S. Korean Nationwide Exploration of Sarcopenia Prevalence and Risk Factors in Late Middle-Aged Women. Healthcare. 2024;12(3):362. 
  45. Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57-65. 
  46. Confortin SC, Meneghini V, Ono LM, et al. Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianopolis, Santa Catarina: EpiFloripa Ageing study. Revista De Nutricao-Brazilian Journal of Nutrition. 2017;30(3):287-96. 
  47. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-95. 
  48. Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953-63. 
  49. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-83. 
  50. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005;82(2):428-34. 
  51. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109. 
  52. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81. 
  53. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25. 
  54. Daskalopoulou C, Wu YT, Pan W, et al. Factors related with sarcopenia and sarcopenic obesity among low- and middle-income settings: the 10/66 DRG study. Sci Rep. 2020;10(1):20453. 
  55. Pang BWJ, Wee SL, Lau LK, et al. Prevalence and Associated Factors of Sarcopenia in Singaporean Adults-The Yishun Study. J Am Med Dir Assoc. 2021;22(4):885 e1- e10. 
  56. Cui YF, Huang C, Momma H, et al. The longitudinal association between alcohol consumption and muscle strength: A population-based prospective study. Journal of Musculoskeletal & Neuronal Interactions. 2019;19(3):294-9. 
  57. Jyothi MS, Reddy KR, Soontarapa K, et al. Membranes for dehydration of alcohols via pervaporation. J Environ Manage. 2019;242:415-29. 
  58. Therakomen V, Petchlorlian A, Lakananurak N. Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: a cross-sectional study. Sci Rep. 2020;10(1):19551.